Mouse experiments were performed according to the guidelines of the Animal Ethics Committee of Kobe University Graduate Scholl of Medicine. Targeting strategy for the disruption of the chemerin gene locus is depicted in Supplementary Fig. 1A , and was performed in the ES cells of TT2 as described (http://www.cdb.riken.jp/arg/ Methods.html). We replaced all the coding regions of chemerin (exon 2) with a neomycin-resistant cassette. We analyzed chemerin-deficient mice derived from two independent clones of the ES cells (#33 and #86, Supplementary Fig. 1b , c) and both lines showed similar phenotypes. Chemerin expressions were completely ablated in the liver ( Supplementary Fig. 1e ), serum ( Supplementary Fig. 1f ) in the (-/-) mice. The results presented here are of studies conducted on mice backcrossed at least for six generations with C57Bl6 background and 7-15-week-old age-matched mice, unless otherwise specified. Genotyping was performed at weaning (21d) on genomic tail DNA. The primers (AC1CASP1; 5'-GAACTGGCACAGCCTAGGAG-3'), (AC1WSP3.1; 5'-CTACAGGTGGCTCTGGAGGA-3') and (PGKS1; TCCACTAAAATGGAAG TTTTTCCT ) were used for 3 primer PCR, producing a 246 (wild type) or 386 (null) bp PCR product ( Supplementary Fig. 1d) .
A 0.6 kb human serum amyloid P enhancer/promoter fragment was used to drive expression of human chemerin in the SAP-hChemerin transgene 1 . Two transgenic lines, #9 (Tg1) and #27 (Tg2), were established in the C57Bl6 background. These lines exhibited similar glucose tolerance in IPGTT, and the lower-expressing line, Tg1, was used in subsequent studies. The primers (GLOBINsense1; GTGCTGGTTGTTGTGCTGTC), (hAC1sense1 ; CTGGAGGAATTTCACAAGCA), and (hAC1antisense1; CTTTGCACTCGGGTTTCTTC) were used for genotyping. Animals were housed up to 5 per cage in a 12 h light/dark cycle (lights on at 0700), with free access to water and chow under specific pathogen-free conditions. Male C57BL/6J and db/db mice were purchased from CLEA Japan. For high-fat diet studies, 8-weeks-old male C57BL/6J mice were fed with a diet containing 45% fat, 10% protein and 35% carbohydrate (Oriental Bioservice, Japan) for 6 weeks. Streptozotocin (STZ)-diabetic mice were generated as previously described 2 . Briefly, for the analysis of chemerin and ChemR23 expression in pancreas, 100mg/kg of STZ (Sigma, St.Louis, MO, USA) in citrate sodium buffer (ph4.5) was administered intraperitoneally to 6-weeks-old male C57BL/6J mice in every week for twice in fasting status. Eight weeks after the first administration, mice were sacrificed and the pancreas was analyzed.
Glucose measurements and intraperitoneal glucose tolerance test
For the intraperitoneal glucose tolerance test, 50% glucose (1.5g/kg body weight) was injected intraperitoneally after a 15-h fasting. Blood was collected from the tail vein at 0, 30, 60, 90 and 120 min after the injection. For insulin measurements, blood was collected at 0, 15 and 30 min after the injection.
Hormone assays
The serum was separated by centrifugation and stored at -80 and assayed using mouse insulin ELISA kits (Shibayagi Inc. Japan), mouse leptin ELISA kits (R&D systems, USA), and mouse serum adiponectin kit (Otsuka assay, Japan). Serum total cholesterol, triglyceride, and NEFA were assayed using Cholesterol E test WAKO, Triglyceride E test WAKO, and NEFA C test WAKO kit from WAKO.
Euglycemic Hyperinsulinemic Clamp Studies
Euglycemic Hyperinsulinemic Clamp Studies were performed as previously described 3 .
Briefly, five to seven days before the clamp, mice were anesthetized with sodium pentobarbital (80-100 mg/kg, ip) and a catheter was inserted into the right internal glucose production (HGP) were calculated as described 4 .
Islet morphometry analysis, immunohistochemistry and immunofluorescence
The pancreas was isolated, fixed in 4% paraformaldehyde and embedded in paraffin.
Consecutive 4 m sections were cut and mounted on slides. The percentage islet area was quantified using Image J software as described previously 5, 6 . 8-weeks-old male C57BL/6J mice were used for the analysis of chemerin and ChemR23 expression. staining was performed as previously described 3 .
Quantitative real time PCR and immunoblotting
Quantitative real-time PCR (QRPCR) was performed, as previously described 9,10 , on a
LightCycler system using the FastStart DNA Master SYBR Green I kit (Roche Diagnostics, Switzerland). Each value was normalized to 36B4 or -actin expression. The sequence of primers is listed below. Immunoblotting analysis was performed as previously described 8, 11 .
Islet isolation and batch incubation
Mouse pancreatic islet isolation and batch incubation were performed as previously 
Perfusion experiments of mouse pancreata
Overnight (12-16 h)-fasted mice at 8-15 weeks of age were used in perfusion experiments as previously described 13 . A littermate in a same-gender pair was used for the experiments (n=5-6/genotype). Briefly, after anesthesia with 80 mg/kg sodium pentobarbital, the superior mesenteric and renal arteries were ligated, and the aorta was tied off just below the diaphragm. The perfusate was infused from a catheter placed in the aorta and collected from the portal vein. The perfusate was Krebs-Ringer bicarbonate HEPES (KRBH) buffer supplemented with 4.6% dextran and 0.25% BSA and gassed with 95% O 2 /5% CO 2 . The flow rate of the perfusate was 1 ml/min. The pancreata were preperfused with KRBH buffer containing 2.8 mmol/l glucose for 10 min of equilibration period and stimulated by 16.7 mmol/l glucose for 5 min. The insulin levels in the perfusate were measured by ELISA kit.
MIN6 cells and knockdown of chemerin and ChemR23
Mouse cell line, MIN6 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 25 mM glucose supplemented with 15% (v/v) heat-inactivated fetal calf serum under humidified conditions of 5% CO 2 , 95% air at 37 °C 14 . After 6h of starvation, the indicated agents were added, incubated for 3 h and chemerin expression was analyzed by QRPCR. For the knockdown of chemerin or ChemR23 in MIN6 cells, shRNA expression vector, pcPURm6i 15 containing target sequence for mouse chemerin or ChemR23 was transfected by reverse transfection method into MIN6 cells using Lipofectamine 2000 reagent (Invitrogen) as previously described 16, 17 , according to the manufacturer's instruction. The target sequence for knock down of chemerin and ChemR23 are as follows; Chemerin, CKD-2:GGAGAAGGCGGAAATGCCCT, CKD-3:AGACCAACTGCCCCAAGAA, CKD -5:AAGCCGGAGTGCACAATCA and CHEMR23, CRKD-1:GCCACAACATGTACACCAG, CRKD-6:GTGCCAAGCTCTG TCTTCA, CRKD-8:GCATGAACCCCATTCTGTA. The vector plasmid was mixed with Lipofectamine 2000 in Opti-MEM I medium and incubated at room temperature for 20 minutes. MIN6 cells were stripped by trypsin-EDTA and incubated in antibiotic-free DMEM with 15% FBS before transfection. The transfection mixture was added to the cells in suspension status. The transfection efficiency was verified using GFP expression vector. Then, the cell were seeded to 96 well plates and incubated for approximately 8 h at 37°C and 5% CO 2 before being replaced with normal culture medium. Measurement of insulin secretion and content was performed as previously described 18 , 48 h after the transfection. The values of insulin were normalized by protein content.
Statistics and data analysis
Results are represented as mean SEM from at least 3 different experiments performed independently, unless stated otherwise. The data were analyzed using an unpaired 
